Suraksha Diagnostic Limited (BOM:544293)

Market Cap	14.33B -9.3%
Revenue (ttm)	3.10B +23.1%
Net Income	321.87M +1.1%
EPS	6.18 +3.5%
Shares Out	n/a
PE Ratio	44.53
Forward PE	35.65
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,851
Open	281.80
Previous Close	279.95
Day's Range	275.00 - 285.65
52-Week Range	224.10 - 353.65
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 21, 2026

About Suraksha Diagnostic

Suraksha Diagnostic Limited operates a chain of diagnostic centers in India. It offers pathology testing services, such as microbiology, serology, molecular biology, histopathology, cytopathology, clinical pathology, and haematology; genomics testing, including microarray, noninvasive prenatal, quantitative fluorescent polymerase chain reaction, fluorescence in situ hybridization, and karyotyping; and radiology testing that includes X ray, magnetic resonance imaging, computed tomography scan, USG, DEXA scan, OPG, and mammography. The company al...

• Industry: Medical Laboratories
• Founded: 1992
• Employees: 1,300
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544293

Financial Performance

In fiscal year 2026, Suraksha Diagnostic's revenue was 3.10 billion, an increase of 23.13% compared to the previous year's 2.52 billion. Earnings were 321.87 million, an increase of 1.14%.